These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24791841)

  • 21. Electron-microscopic evaluation of collagen fibrils after topical corticosteroid therapy.
    Groniowska M; Dabrowski J; Maciejewski W; Walski M
    Dermatologica; 1976; 152 Suppl 1():147-53. PubMed ID: 133837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultra-high-frequency ultrasound monitoring of plaque psoriasis during ixekizumab treatment.
    Dini V; Janowska A; Faita F; Panduri S; Benincasa BB; Izzetti R; Romanelli M; Oranges T
    Skin Res Technol; 2021 Mar; 27(2):277-282. PubMed ID: 33529441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of a topical corticosteroid on short-contact high-dose dithranol therapy.
    Swinkels OQ; Prins M; Tosserams EF; Gerritsen MJ; Van Der Valk PG; Van De Kerkhof PC
    Br J Dermatol; 2001 Jul; 145(1):63-9. PubMed ID: 11453908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-frequency sonography in the evaluation of psoriasis: nail and skin involvement.
    Gutierrez M; Wortsman X; Filippucci E; De Angelis R; Filosa G; Grassi W
    J Ultrasound Med; 2009 Nov; 28(11):1569-74. PubMed ID: 19854972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ranking of the antipsoriatic effect of various topical corticosteroids applied under a hydrocolloid dressing--skin-thickness, blood-flow and colour measurements compared to clinical assessments.
    Broby-Johansen U; Karlsmark T; Petersen LJ; Serup J
    Clin Exp Dermatol; 1990 Sep; 15(5):343-8. PubMed ID: 2225536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of ultra-high-frequency ultrasound in the evaluation of skin involvement in systemic sclerosis: a preliminary report.
    Naredo E; Pascau J; Damjanov N; Lepri G; Gordaliza PM; Janta I; Ovalles-Bonilla JG; López-Longo FJ; Matucci-Cerinic M
    Rheumatology (Oxford); 2020 Jul; 59(7):1671-1678. PubMed ID: 31665474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of methylprednisolone aceponate, tacrolimus and combination thereof in the psoriasis plaque test using sum score, 20-MHz-ultrasonography and optical coherence tomography.
    Buder K; Knuschke P; Wozel G
    Int J Clin Pharmacol Ther; 2010 Dec; 48(12):814-20. PubMed ID: 21084037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mometasone furoate ointment 0.1% vs. hydrocortisone ointment 1.0% in psoriasis. Atrophogenic potential.
    Katz HI; Prawer SE; Watson MJ; Scull TA; Peets EA
    Int J Dermatol; 1989 Jun; 28(5):342-4. PubMed ID: 2753592
    [No Abstract]   [Full Text] [Related]  

  • 29. A clinical evaluation of tazarotene 0.1% gel, with and without a high- or mid-high-potency corticosteroid, in patients with stable plaque psoriasis.
    Green L; Sadoff W
    J Cutan Med Surg; 2002; 6(2):95-102. PubMed ID: 11992180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative effects of calcipotriol ointment (50 micrograms/g) and 5% coal tar/2% allantoin/0.5% hydrocortisone cream in treating plaque psoriasis.
    Pinheiro N
    Br J Clin Pract; 1997; 51(1):16-9. PubMed ID: 9158266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the atrophogenic potential of hydrocortisone 1% cream and pimecrolimus 1% cream in uninvolved forehead skin of patients with atopic dermatitis using optical coherence tomography.
    Aschoff R; Schmitt J; Knuschke P; Koch E; Bräutigam M; Meurer M
    Exp Dermatol; 2011 Oct; 20(10):832-6. PubMed ID: 21771098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical hydrocortisone 17-butyrate 21-propionate in the treatment of inflammatory skin diseases: pharmacological data, clinical efficacy, safety and calculation of the therapeutic index.
    Fölster-Holst R; Abeck D; Torrelo A
    Pharmazie; 2016 Mar; 71(3):115-21. PubMed ID: 27183704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy.
    Yamamoto T; Nishioka K
    Skin Pharmacol Appl Skin Physiol; 2003; 16(1):50-8. PubMed ID: 12566829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of fluticasone propionate ointment, 0.005%, and hydrocortisone-17-butyrate ointment, 0.1%, in the treatment of psoriasis.
    Nurnberger FG
    Cutis; 1996 Feb; 57(2 Suppl):39-44. PubMed ID: 8646868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy.
    Castela E; Archier E; Devaux S; Gallini A; Aractingi S; Cribier B; Jullien D; Aubin F; Bachelez H; Joly P; Le Maître M; Misery L; Richard MA; Paul C; Ortonne JP
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():47-51. PubMed ID: 22512680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasound description and quantification of irritant reactions induced by dithranol at different concentrations. A comparison with visual assessment and colorimetric measurements.
    Schiavi ME; Belletti B; Seidenari S
    Contact Dermatitis; 1996 Apr; 34(4):272-7. PubMed ID: 8730166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis.
    Vissers WH; Berends M; Muys L; van Erp PE; de Jong EM; van de Kerkhof PC
    Exp Dermatol; 2004 Feb; 13(2):106-12. PubMed ID: 15009104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo.
    Serup J; Holm P
    Dermatologica; 1985; 170(4):189-94. PubMed ID: 3888708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study of potential skin atrophy following topical application of weak corticosteroids.
    Black MM; Platt NE; Mugglestone CJ
    Curr Med Res Opin; 1981; 7(7):463-70. PubMed ID: 7261664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective persistence of dermal CD8+ T cells in lesional plaque psoriasis after clobetasol-17 propionate treatment.
    Bovenschen HJ; Vissers WH; Seyger MM; van de Kerkhof PC
    Acta Derm Venereol; 2005; 85(2):113-7. PubMed ID: 15823902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.